Global Multiplex Assays Market Size, Share, Trends, Industry Growth by Type (Cell, Protein, Nucleic Acid), by Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others), by Application, by End-User, by Region, and Forecast to 2028

Report ID: RC147855 | Report Format: PDF + Excel | Starting Price: 3600/- USD | Last Updated: June 26th, 2023

The global multiplex assays market size accounted for over USD 3 billion in 2021 and is expected to experience a robust CAGR of over 7% during the forecast period 2022 to 2028. The rising prevalence of chronic disease, which generally needs multiplex tests for diagnosis, is a primary factor driving the market growth. Furthermore, the increasing number of cancer cases around the globe is anticipated to fuel market growth over the forecast period. According to the information shared by the World Health Organization (WHO), cancer is a leading cause of death, and about 10 million death recorded in 2020 due to cancer. Moreover, the increasing awareness of disease diagnosis, the adoption of companion diagnostics, and the increasing research to reduce the operation cost are further anticipated to fuel the market.

Market Drivers:

Advantages over traditional methods: Multiplex assays offer significant advantages over traditional single-plex assays by allowing the simultaneous detection of multiple analytes within a single sample. This leads to cost and time savings, increased efficiency, and reduced sample volume requirements, making multiplex assays highly attractive to researchers and clinicians.

Increasing demand for personalized medicine: With the growing focus on personalized medicine, there is a rising need for diagnostic tools that can provide comprehensive and precise information about an individual’s health status. Multiplex assays enable the detection of multiple biomarkers in a single sample, facilitating a more accurate diagnosis and treatment selection, thereby driving their adoption in personalized medicine.

Rising prevalence of chronic diseases: The increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and infectious diseases, is fueling the demand for efficient diagnostic methods. Multiplex assays allow the simultaneous measurement of multiple disease-related biomarkers, enabling early detection, accurate prognosis, and effective monitoring of these conditions.

Technological advancements: Continuous advancements in assay technologies, including improvements in detection methods, assay sensitivity, and automation, have significantly enhanced the performance and reliability of multiplex assays. These advancements have expanded their applications in various fields, such as clinical diagnostics, drug discovery, and research, leading to increased market adoption.

Cost-effectiveness and time savings: Multiplex assays offer cost-effective solutions by reducing the overall cost per test and saving time compared to traditional single-plex assays. The ability to analyze multiple analytes in a single run minimizes reagent and labor costs while improving laboratory workflow efficiency, making multiplex assays an attractive option for diagnostic laboratories.

Growing research activities: Multiplex assays are widely used in research applications to study complex biological systems, identify novel biomarkers, and understand disease mechanisms. The increasing focus on biomedical research and the need for high-throughput analysis drive the demand for multiplex assays in research laboratories and academic institutions.

Point-of-care testing (POCT) applications: Multiplex assays are also finding applications in point-of-care testing, enabling rapid and accurate diagnosis at the patient’s bedside or in remote settings. The ability to detect multiple analytes in a single sample within a short turnaround time is particularly valuable in emergency situations and resource-limited settings, driving the demand for multiplex assays in POCT.

Growing adoption in companion diagnostics: Companion diagnostics play a crucial role in personalized medicine by identifying patients who are likely to benefit from specific therapies. Multiplex assays are well-suited for companion diagnostics as they can simultaneously assess multiple biomarkers associated with drug response, treatment efficacy, and patient stratification.

Market Snapshot:

Benchmark Year 2022
Market Size > USD 3 Billion in 2021
Market Growth (CAGR) > 7% (2023-2030)
Largest Market Share North America
Analysis Period 2020-2030
Market Players Thermo Fisher Scientific, Inc., Abcam, Merck KGaA, Becton, Dickinson and Company, and Bio-Rad Laboratories, Inc.

Market Insights:

By type, the protein-based multiplex assays segment is expected to register the fastest CAGR by 2028

The global multiplex assays market is bifurcated into type, technology, application, end-user, and geography. On the basis of type, the market is further segmented into cell-based multiplex assays, protein multiplex assays, and nucleic acid multiplex assays. The protein-based multiplex assays segment dominated the global market in 2020 and is estimated to grow at the fastest growth rate over the forecast period. The increasing inclination towards proteomics study clinical diagnostics and biomarker research is one of the prominent factor to drive the segment growth. Furthermore, the increasing use of the technology in the analysis of various types of infectious diseases and autoimmune diseases is expected to fuel the segment growth.

By technology, the flow cytometry segment dominated the global multiplex assays market

On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and others. The flow cytometry segment dominated the global multiplex assays market in 2020 and expected to register the fastest growth rate over the forecast period. The wide applications of the technology in detection and analysis of RNA, protein expression, and cell health characterization is a major factor to drive the segment growth. Furthermore, the easy operation, flexibility to run a large number of samples, and accuracy are some other advantages as well increasing focus on development for flow cytometry is expected to drive the segment growth.

By end-user, the pharmaceuticals & biotech companies segment is expected to dominate the market by 2028

On the basis of end-user, the market is segmented into pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories, and others. The pharmaceuticals and biotech companies end-user segment dominated the global multiplex assays market in 2020. The increasing number of biotech companies in developing economies is a major factor to drive the segment growth. Furthermore, the increasing adoption of the technology in the diagnosis of various diseases such as cancer, immune system disease, and other infectious diseases is expected to propel the segment growth over the forecast period.

Multiplex Assays Market Share & Trends

To know more about the report, request sample papers

The multiplex assays comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2022 to 2028. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The multiplex assays market research report presents the analysis of each segment from 2019 to 2028 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2019-20 – Historical Year
  • 2021 – Base Year
  • 2022-2028 – Forecast Period

Market Segmentation:

By Type:

  • Cell-Based Multiplex Assays
  • Protein Multiplex Assays
    • Planar Protein Assays
    • Bead-Based Protein Assays
    • Others
  • Nucleic Acid Multiplex Assays
    • Planar Nucleic Acid Assays
    • Bead-Based Nucleic Acid Assays
    • Others

By Technology:

  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Others

By Application:

  • Research & Development
    • Drug Discovery & Development
    • Biomarker Discovery & Validation
  • Clinical Diagnostics
    • Infectious Diseases
    • Cancer
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Nervous System Disorders
    • Metabolism & Endocrinology Disorders
    • Others

By End-User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, North America dominated the global multiplex assays market in 2020 and is expected to hold a large market share of over 40% of the market by the end of the analysis period.  The rising awareness of disease diagnosis and the growing prevalence of chronic diseases are some major factors to drive the market growth in the region. Furthermore, the easy availability and the presence of diagnostics labs are further anticipated to fuel the market growth in North America.  Moreover, the increasing investment in R&D, government supportive policies, and the good structures of healthcare infrastructure are expected to propel the market over the forecast period years.

Competitive Assessment:

Some of the major market players operating in the global multiplex assays market are Thermo Fisher Scientific, Inc., Abcam, Merck KGaA, Becton, Dickinson and Company, and Bio-Rad Laboratories, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

  • Thermo Fisher Scientific, Inc.
  • Abcam
  • Merck KGaA
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Promega Corporation
  • Luminex Corporation
  • Enzo Life Sciences, Inc.

Key Questions Answered by Multiplex Assays Market Report

  • Global multiplex assays market forecasts from 2022-2028
  • Regional market forecasts from 2022-2028 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2022-2028 covering 15 major countries from the regions as mentioned above
  • Multiplex assays submarket forecasts from 2022-2028 covering the market by type, by technology, by application, by end-user, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis about the market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level multiplex assays markets from 2022-2028
  • Competitive Landscape and market positioning of top 10 players operating in the market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Multiplex Assays Market Portraiture
2.2. Global Multiplex Assays Market, by Type, 2021 (USD Mn)
2.3. Global Multiplex Assays Market, by Technology, 2021 (USD Mn)
2.4. Global Multiplex Assays Market, by Application, 2021 (USD Mn)
2.5. Global Multiplex Assays Market, by Geography, 2021 (USD Mn)

 

3. Global Multiplex Assays Market Analysis


3.1. Multiplex Assays Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis

 

4. Global Multiplex Assays Market By Type, 2019 – 2028 (USD Mn)


4.1. Overview
4.2. Cell-Based Multiplex Assays
4.3. Protein Multiplex Assays
4.3.1. Planar Protein Assays
4.3.2. Bead-Based Protein Assays
4.3.3. Others
4.4. Nucleic Acid Multiplex Assays
4.4.1. Planar Nucleic Acid Assays
4.4.2. Bead-Based Nucleic Acid Assays
4.4.3. Others

 

5. Global Multiplex Assays Market By Technology, 2019 – 2028 (USD Mn)


5.1. Overview
5.2. Flow Cytometry
5.3. Fluorescence Detection
5.4. Luminescence
5.5. Multiplex Real-Time PCR
5.6. Others

 

6. Global Multiplex Assays Market By Application, 2019 – 2028 (USD Mn)


6.1. Overview
6.2. Research & Development
6.2.1. Drug Discovery & Development
6.2.2. Biomarker Discovery & Validation
6.3. Clinical Diagnostics
6.3.1. Infectious Diseases
6.3.2. Cancer
6.3.3. Cardiovascular Diseases
6.3.4. Autoimmune Diseases
6.3.5. Nervous System Disorders
6.3.6. Metabolism & Endocrinology Disorders
6.3.7. Others

 

7. Global Multiplex Assays Market By End-User, 2019 – 2028 (USD Mn)


7.1. Overview
7.2. Pharmaceutical & Biotechnology Companies
7.3. Hospitals & Research Institutes
7.4. Reference Laboratories
7.5. Others

 

8. North America Multiplex Assays Market Analysis and Forecast, 2019 – 2028 (USD Mn)


8.1.1. Overview
8.1.2. North America Multiplex Assays Market by Type (2019-2028 USD Mn)
8.1.3. North America Multiplex Assays Market by Technology (2019-2028 USD Mn)
8.1.4. North America Multiplex Assays Market by Application (2019-2028 USD Mn)
8.1.5. North America Multiplex Assays Market by End-User (2019-2028 USD Mn)
8.1.6. North America Multiplex Assays Market by Country (2019-2028 USD Mn)
8.1.6.1. U.S.
8.1.6.1.1. U.S. Multiplex Assays Market by Type (2019-2028 USD Mn)
8.1.6.1.2. U.S. Multiplex Assays Market by Technology (2019-2028 USD Mn)
8.1.6.1.3. U.S. Multiplex Assays Market by Application (2019-2028 USD Mn)
8.1.6.1.4. U.S. Multiplex Assays Market by End-User (2019-2028 USD Mn)
8.1.6.2. Canada
8.1.6.2.1. Canada Multiplex Assays Market by Type (2019-2028 USD Mn)
8.1.6.2.2. Canada Multiplex Assays Market by Technology (2019-2028 USD Mn)
8.1.6.2.3. Canada Multiplex Assays Market by Application (2019-2028 USD Mn)
8.1.6.2.4. Canada Multiplex Assays Market by End-User (2019-2028 USD Mn)

 

9. Europe Multiplex Assays Market Analysis and Forecast, 2019 – 2028 (USD Mn)


9.1.1. Overview
9.1.2. Europe Multiplex Assays Market by Type (2019-2028 USD Mn)
9.1.3. Europe Multiplex Assays Market by Technology (2019-2028 USD Mn)
9.1.4. Europe Multiplex Assays Market by Application (2019-2028 USD Mn)
9.1.5. Europe Multiplex Assays Market by End-User (2019-2028 USD Mn)
9.1.6. Europe Multiplex Assays Market by Country (2019-2028 USD Mn)
9.1.6.1. Germany
9.1.6.1.1. Germany Multiplex Assays Market by Type (2019-2028 USD Mn)
9.1.6.1.2. Germany Multiplex Assays Market by Technology (2019-2028 USD Mn)
9.1.6.1.3. Germany Multiplex Assays Market by Application (2019-2028 USD Mn)
9.1.6.1.4. Germany Multiplex Assays Market by End-User (2019-2028 USD Mn)
9.1.6.2. U.K.
9.1.6.2.1. U.K. Multiplex Assays Market by Type (2019-2028 USD Mn)
9.1.6.2.2. U.K. Multiplex Assays Market by Technology (2019-2028 USD Mn)
9.1.6.2.3. U.K. Multiplex Assays Market by Application (2019-2028 USD Mn)
9.1.6.2.4. U.K. Multiplex Assays Market by End-User (2019-2028 USD Mn)
9.1.6.3. France
9.1.6.3.1. France Multiplex Assays Market by Type (2019-2028 USD Mn)
9.1.6.3.2. France Multiplex Assays Market by Technology (2019-2028 USD Mn)
9.1.6.3.3. France Multiplex Assays Market by Application (2019-2028 USD Mn)
9.1.6.3.4. France Multiplex Assays Market by End-User (2019-2028 USD Mn)
9.1.6.4. Italy
9.1.6.4.1. Italy Multiplex Assays Market by Type (2019-2028 USD Mn)
9.1.6.4.2. Italy Multiplex Assays Market by Technology (2019-2028 USD Mn)
9.1.6.4.3. Italy Multiplex Assays Market by Application (2019-2028 USD Mn)
9.1.6.4.4. Italy Multiplex Assays Market by End-User (2019-2028 USD Mn)
9.1.6.5. Rest of Europe
9.1.6.5.1. Rest of Europe Multiplex Assays Market by Type (2019-2028 USD Mn)
9.1.6.5.2. Rest of Europe Multiplex Assays Market by Technology (2019-2028 USD Mn)
9.1.6.5.3. Rest of Europe Multiplex Assays Market by Application (2019-2028 USD Mn)
9.1.6.5.4. Rest of Europe Multiplex Assays Market by End-User (2019-2028 USD Mn)

 

10. Asia Pacific Multiplex Assays Market Analysis and Forecast, 2019 – 2028 (USD Mn)


10.1.1. Overview
10.1.2. Asia Pacific Multiplex Assays Market by Type (2019-2028 USD Mn)
10.1.3. Asia Pacific Multiplex Assays Market by Technology (2019-2028 USD Mn)
10.1.4. Asia Pacific Multiplex Assays Market by Application (2019-2028 USD Mn)
10.1.5. Asia Pacific Multiplex Assays Market by End-User (2019-2028 USD Mn)
10.1.6. Asia Pacific Multiplex Assays Market by Country (2019-2028 USD Mn)
10.1.6.1. China
10.1.6.1.1. China Multiplex Assays Market by Type (2019-2028 USD Mn)
10.1.6.1.2. China Multiplex Assays Market by Technology (2019-2028 USD Mn)
10.1.6.1.3. China Multiplex Assays Market by Application (2019-2028 USD Mn)
10.1.6.1.4. China Multiplex Assays Market by End-User (2019-2028 USD Mn)
10.1.6.2. Japan
10.1.6.2.1. Japan Multiplex Assays Market by Type (2019-2028 USD Mn)
10.1.6.2.2. Japan Multiplex Assays Market by Technology (2019-2028 USD Mn)
10.1.6.2.3. Japan Multiplex Assays Market by Application (2019-2028 USD Mn)
10.1.6.2.4. Japan Multiplex Assays Market by End-User (2019-2028 USD Mn)
10.1.6.3. Rest of Asia Pacific
10.1.6.3.1. Rest of Asia Pacific Multiplex Assays Market by Type (2019-2028 USD Mn)
10.1.6.3.2. Rest of Asia Pacific Multiplex Assays Market by Technology (2019-2028 USD Mn)
10.1.6.3.3. Rest of Asia Pacific Multiplex Assays Market by Application (2019-2028 USD Mn)
10.1.6.3.4. Rest of Asia Pacific Multiplex Assays Market by End-User (2019-2028 USD Mn)

 

11. Latin America (LATAM) Multiplex Assays Market Analysis and Forecast, 2019 – 2028 (USD Mn)


11.1.1. Overview
11.1.2. Latin America Multiplex Assays Market by Type (2019-2028 USD Mn)
11.1.3. Latin America Multiplex Assays Market by Technology (2019-2028 USD Mn)
11.1.4. Latin America Multiplex Assays Market by Application (2019-2028 USD Mn)
11.1.5. Latin America Multiplex Assays Market by End-User (2019-2028 USD Mn)
11.1.6. Latin America Multiplex Assays Market by Country (2019-2028 USD Mn)
11.1.6.1. Brazil
11.1.6.1.1. Brazil Multiplex Assays Market by Type (2019-2028 USD Mn)
11.1.6.1.2. Brazil Multiplex Assays Market by Technology (2019-2028 USD Mn)
11.1.6.1.3. Brazil Multiplex Assays Market by Application (2019-2028 USD Mn)
11.1.6.1.4. Brazil Multiplex Assays Market by End-User (2019-2028 USD Mn)
11.1.6.2. Mexico
11.1.6.2.1. Mexico Multiplex Assays Market by Type (2019-2028 USD Mn)
11.1.6.2.2. Mexico Multiplex Assays Market by Technology (2019-2028 USD Mn)
11.1.6.2.3. Mexico Multiplex Assays Market by Application (2019-2028 USD Mn)
11.1.6.2.4. Mexico Multiplex Assays Market by End-User (2019-2028 USD Mn)
11.1.6.3. Rest of Latin America
11.1.6.3.1. Rest of Latin America Multiplex Assays Market by Type (2019-2028 USD Mn)
11.1.6.3.2. Rest of Latin America Multiplex Assays Market by Technology (2019-2028 USD Mn)
11.1.6.3.3. Rest of Latin America Multiplex Assays Market by Application (2019-2028 USD Mn)
11.1.6.3.4. Rest of Latin America Multiplex Assays Market by End-User (2019-2028 USD Mn)

 

12. Middle East and Africa Multiplex Assays Market Analysis and Forecast, 2019 – 2028 (USD Mn)


12.1.1. Overview
12.1.2. MEA Multiplex Assays Market by Type (2019-2028 USD Mn)
12.1.3. MEA Multiplex Assays Market by Technology (2019-2028 USD Mn)
12.1.4. MEA Multiplex Assays Market by Application (2019-2028 USD Mn)
12.1.5. MEA Multiplex Assays Market by End-User (2019-2028 USD Mn)
12.1.6. Middle East and Africa Multiplex Assays Market, by Country (2019-2028 USD Mn)
12.1.6.1. GCC
12.1.6.1.1. GCC Multiplex Assays Market by Type (2019-2028 USD Mn)
12.1.6.1.2. GCC Multiplex Assays Market by Technology (2019-2028 USD Mn)
12.1.6.1.3. GCC Multiplex Assays Market by Application (2019-2028 USD Mn)
12.1.6.1.4. GCC Multiplex Assays Market by End-User (2019-2028 USD Mn)
12.1.6.2. South Africa
12.1.6.2.1. South Africa Multiplex Assays Market by Type (2019-2028 USD Mn)
12.1.6.2.2. South Africa Multiplex Assays Market by Technology (2019-2028 USD Mn)
12.1.6.2.3. South Africa Multiplex Assays Market by Application (2019-2028 USD Mn)
12.1.6.2.4. South Africa Multiplex Assays Market by End-User (2019-2028 USD Mn)
12.1.6.3. Rest of MEA
12.1.6.3.1. Rest of MEA Multiplex Assays Market by Type (2019-2028 USD Mn)
12.1.6.3.2. Rest of MEA Multiplex Assays Market by Technology (2019-2028 USD Mn)
12.1.6.3.3. Rest of MEA Multiplex Assays Market by Application (2019-2028 USD Mn)
12.1.6.3.4. Rest of MEA Multiplex Assays Market by End-User (2019-2028 USD Mn)

 

13. Company Profiles


13.1. Thermo Fisher Scientific, Inc.
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. Abcam
13.2.1. Business Description
13.2.2. Financial Health and Budget Allocation
13.2.3. Product Positions/Portfolio
13.2.4. Recent Development
13.2.5. SWOT Analysis
13.3. Merck KGaA
13.3.1. Business Description
13.3.2. Financial Health and Budget Allocation
13.3.3. Product Positions/Portfolio
13.3.4. Recent Development
13.3.5. SWOT Analysis
13.4. Becton, Dickinson and Company
13.4.1. Business Description
13.4.2. Financial Health and Budget Allocation
13.4.3. Product Positions/Portfolio
13.4.4. Recent Development
13.4.5. SWOT Analysis
13.5. Bio-Rad Laboratories, Inc.
13.5.1. Business Description
13.5.2. Financial Health and Budget Allocation
13.5.3. Product Positions/Portfolio
13.5.4. Recent Development
13.5.5. SWOT Analysis
13.6. Illumina, Inc.
13.6.1. Business Description
13.6.2. Financial Health and Budget Allocation
13.6.3. Product Positions/Portfolio
13.6.4. Recent Development
13.6.5. SWOT Analysis
13.7. Perkinelmer, Inc.
13.7.1. Business Description
13.7.2. Financial Health and Budget Allocation
13.7.3. Product Positions/Portfolio
13.7.4. Recent Development
13.7.5. SWOT Analysis
13.8. Promega Corporation
13.8.1. Business Description
13.8.2. Financial Health and Budget Allocation
13.8.3. Product Positions/Portfolio
13.8.4. Recent Development
13.8.5. SWOT Analysis
13.9. Luminex Corporation
13.9.1. Business Description
13.9.2. Financial Health and Budget Allocation
13.9.3. Product Positions/Portfolio
13.9.4. Recent Development
13.9.5. SWOT Analysis
13.10. Enzo Life Sciences, Inc.
13.10.1. Business Description
13.10.2. Financial Health and Budget Allocation
13.10.3. Product Positions/Portfolio
13.10.4. Recent Development
13.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Global Multiplex Assays Market Size, Share, Trends, Industry Growth by Type (Cell, Protein, Nucleic Acid), by Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others), by Application, by End-User, by Region, and Forecast to 2028 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying
Schedule a Call


Select License Type
$ 3600/- Single User License
$ 6995/- Corporate License

Paypal Certified Payment
For Any Assitance

Email: sales@researchcorridor.com
Schedule a Call
Request Customization

Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price

Impacts of COVID-19
COVID-19 Impact on the Global Multiplex Assays Market Size, Share, Trends, Industry Growth by Type (Cell, Protein, Nucleic Acid), by Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others), by Application, by End-User, by Region, and Forecast to 2028 Market

Recent Market Insights

Our Clients